This study was designed to analyze biomarker-related publications and patent trends which biobanks could consider in planning biosample collections for biomarker research. Methods: Publications and patents containing the term "biomarker" in the title published between 1998 to 2017 were retrieved using Scopus database and Google Patents search engine. Results: Over the last 20 years there has been a steady increase in biomarker-related publications and patents; however this has slowed for patents over the last few years. Publications in 2017 that contained blood, serum, and plasma search terms in the abstract accounted for 50%, and serum as a search term in the title and abstract was more numerous than those containing blood, plasma, tissue, or urine. Bloodrelated patents were the most common patent in the last 10 years, and accounted for 110 patents in 2017. Biomarker-related publications since 2010 containing RNA and protein search terms in the title and abstract, were more numerous than those containing DNA and metabolite search terms. More than 27% of biomarker-related publications in 2017 and 21% of biomarker-related patents were associated with cancer.
Introduction
Recently, medicine has been moving toward a more personalized, precision medicine, based on a patient's genetic, environmental, and clinical characteristics. For the successful implementation of personalized, precision medicine it is imperative that new diagnostic and prognostic biomarkers specific to disease subtypes and individual patients are continually discovered [1] . Current and prospective biomarkers of disease include DNA, RNA, protein, and metabolite biomarkers [2] [3] [4] [5] [6] which could be used for early detection, prognosis, prediction of treatment response, or monitoring of disease recurrence [2, 7] . Protein assays are the most widely used test for biomarkers of disease that are routinely used in clinical analysis [8] , but at the forefront of this research is the challenge to discover new DNA, RNA, and metabolite biomarkers as well as new protein biomarkers for various diseases.
Biobanks need to secure biosamples (such as human blood, serum, plasma, tissue, and urine) suitable for biomarker discovery and clinical application and to do this, an understanding of the trends in biomarker-related publications and patents would be highly relevant.
Geyer et al reported the trends in the literature associated with plasma biomarker studies and mass spectrometry-based proteomics [8] . In this study, the trends in biomarker-related publications and patents in the last 20 years depending on the type of biosample, type of analyte, or biomarker discovery purposes continually increase. The Scopus database and Google Patents search engine were used for literature and patent analyses, respectively. The Scopus database is 1 of the most common bibliographic databases and has more than 59,000 references containing the term "biomarker" in the title. This study will provide information that could help biobanks collect biosamples suitable for biomarker discovery and clinical application.
Materials and Methods

Publication trend analysis
Scientific publication trends related to biomarker were analyzed using Elsevier's Scopus database (www.scopus.com) in March 2018. Publications containing the term "biomarker" in the title which were published from 1998 to 2017 were retrieved. For the literature published in 2017, some pertinent information such as the subject area, document type, source title, author's country, and source type was investigated. All publications belonged to 1 or more subject areas. Publications containing search terms for various biosamples (blood, serum, plasma, tissue, and urine) and analytes (DNA, RNA, microRNA, protein, and metabolite) in the title or the abstract were extracted from the retrieved biomarker-related publications, respectively. Furthermore, publications containing search terms related to biomarker discovery purposes (cancer, prognosis, therapy, diagnosis, and predictive) in the title or abstract were extracted from the retrieved biomarker-related publications.
The search terms were queried in the database of publication titles and abstracts, and asterisks were used to retrieve publications including derivations of the search strings. The document types of the searched publications included article, article in press, abstract report, book, book chapter, conference paper, editorial, letter, note, review, and short survey.
The search strings were as follows: biomarker ("biomarker*"), blood ("blood" OR "whole blood"), serum ("serum" OR "sera"), plasma ("plasma"), tissue ("tissue*"), urine ("urine" OR "urinary"), DNA ("DNA" OR "SNP" OR "genome*" OR "genomic*" OR "single nucleotide polymorphism*" OR "copy number variation*"), RNA ("RNA" OR "mRNA*" OR "miRNA*" OR "microRNA*" OR "gene expression*" OR "transcript*" OR "transcriptome*"), microRNA ("miRNA*"
OR "microRNA*"), protein ("protein*" OR "proteome*" OR "proteomic*"), metabolite ("metabolite*" OR "metabolome*"
OR "metabolomic*"), cancer ("cancer" OR "carcinoma"), prognosis ("prognosis" OR "prognostic"), therapy ("therapy" OR "therapeutic" OR "treatment"), diagnosis ("diagnosis" OR "diagnostic"), and predictive ("predictive" OR "predict*").
Patent trend analysis
Biomarker-related patent trends were analyzed using the Google Patents search engine (Google Inc., Mountain View, California, USA) in March 2018. Patents containing the term "biomarker" in the title which was published between 1998 to 2017 were retrieved. Patents containing search terms for various biosamples (blood, serum, plasma, tissue, and urine) in the abstract were extracted from the retrieved biomarkerrelated patents. The search strings, which were queried in the database of patent titles or abstracts, were the same as those used for the publication trend analysis.
Statistical analysis
Linear regression analysis was performed to assess annual publication numbers and patent trends associated with biomarkers, using SPSS, version 18.0 (SPSS, Chicago, IL, USA).
In this analysis, the number of publications and patents published each year was used as a dependent variable and the year of publication was analyzed as an independent variable.
Statistical significance was reached when p < 0.05.
Results
Publications related to biomarker
Publications containing the term "biomarker" in the title which were published between 1998 and 2017 were retrieved using the Scopus database. The number of biomarker-related publications has increased steadily over the past 20 years Classifying the retrieved publications by subject area, showed that "medicine" was the major subject area (4,712; 64.4%), followed by "biochemistry, genetics, and molecular biology" (2,496; 34.1%) ( Table 1 ). The retrieved publications were mostly articles (5,456; 74.6%) and generally published by researchers in the United States (2,006; 27.4%) and China (1,318; 18.0%).
Biomarker-related publications by the type of biosample
Publications containing search words for various biosamples such as blood, serum, plasma, tissue, and urine that were contained in either the title or the abstract were extracted from all the retrieved biomarker-related publications ( Figure 2 ).
The number of blood, serum, plasma, tissue, and urine-related publications (except for publications containing the term "tissue" in the title) showed increasing trends over the past 20 years, respectively. Amongst them, serum-related publications more than the number of plasma-related publications. In title searches in 2017, urine-related publications were the second highest followed by plasma, blood, and tissue. In case of abstract searches, blood-related publications were the second most common, followed by tissue, plasma, and urine.
Biomarker-related publications by the type of analyte
Publications containing search words for various analytes (such as DNA, RNA, protein, and metabolite) in the title or the abstract were extracted from all the retrieved biomarker- 
Biomarker-related publications by biomarker discovery purposes
Publications containing search terms related to biomarker discovery purposes, in the title or the abstract were extracted from all the retrieved biomarker-related publications ( Figure   5 ). Publications over the last 20 years containing "cancer" as a search term in the title were about 3 times those containing other search terms (prognosis, therapy, diagnosis, and predictive). Conversely, the number of publications containing "cancer" as a search word in the abstract was generally similar to the number of other publications (except for publications on "prognosis" as a search word). Publications in 2017
containing "cancer" as a search term in the title accounted for 1,617 publications, and in the abstract accounted for 2,002 publications (22.1% and 27.4% of biomarker-related publications), respectively.
Patents related to biomarker
A search for patents containing the term "biomarker" in the title published between 1998 and 2017 was carried out using Google Patents search engine (https://patents.google. com). Biomarker-related patents showed an increasing trend over the past 20 years, but has slowed in recent years ( Figure   6 ). There were 1,666 biomarker-related patents published in 2017. Patents containing search terms for blood, serum, plasma, tissue, and urine in the abstract were extracted from the retrieved biomarker-related patents ( Figure 7) . In general, blood-related patents were the most common and urine- Figure 5 . Literature containing search terms related to biomarker discovery purposes in the title (A) and abstract (B). These were extracted from the biomarker-related publications. In 2017, more than 27% of biomarker-related publications and 21% of biomarker-related patents were associated with cancer. Cancer is one of the leading causes of death worldwide.
In the United States of Americain 2014, deaths due to cancer represented 22.5% of all deaths [22] and in Korea in the same year 28.6% of all deaths were due to cancer [23] . (Figure 7 ).
Discussion
The Of the retrieved biomarker-related publications the number of serum-related publications was recently greater than blood, plasma, tissue, and urine-related publications. In title searches in 2017, there were twice as many serum-related publications as blood and tissue-related publications. In abstract searches in 2017, there were twice as many serum-related publications as urine-related publications. Of the retrieved biomarker-related patents, the number of serum-related patents was higher than plasma and urine-related patents. These publication and patent trends should be considered when determining type and quantity of biosample collection.
Analysis of the retrieved biomarker-related publications by the type of analyte, publications containing RNA and protein search strings in the title and abstract, were much more than those containing DNA and metabolite search strings and have been since 2010. RNA and protein profiles can vary depending on pre-analytical (collection, processing, transport, and storage conditions of biosamples) and analytical variables (type of analyte and method of analysis) [9] [10] [11] [12] . Therefore, appropriate conditions for the collection and handling of the biosample may be different [10] . Biobanks could secure biosamples from several hospitals or medical facilities according to the researcher's detail requests (participant's information, type and amount of biosamples, conditions for collecting, processing, could be defined as "evidence-based biobanking."
This study shows trends in biomarker-related publications and patents by the type of biosample, analyte, or biomarker for discovery purposes and this information could help biobanks determine the quantity of biosample collection by the type of biosample. The observations in this study could also be considered in establishing SOPs, and biobanking system to secure biosamples for clinical application.
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